In this episode, listen to experts discuss how recently approved agents for migraine and cluster headache are impacting current diagnostic and treatment paradigms.

CME credit for this program has expired. But, if you'd like to give us feedback, please click or go to https://survey.sogosurvey.com/r/lxVeeG.

For more information on this activity including learning objectives and faculty disclosures, visit us at https://activities.efficientcme.com/CIN/migraine.